Naval Daver, MD, is an Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center in Houston, TX.
Dr Daver received his MD from Grant Medical College and Sir J.J. Group of Hospitals in Mumbai, India. He then completed a research fellowship, clinical residency and clinical fellowship in succession at Baylor College of Medicine in Houston, TX. He serves on numerous Institutional Committees, including the MD Anderson Department of Leukemia Fellowship Steering Committee.
Speaking on immunotherapy and epigenetics in leukemia
With a strong research profile, Dr Daver is involved in a range of clinical trials and research, including that looking into immunotherapy, epigenetics and the potential of minimal residual disease (MRD) monitoring. He also shares the latest hematology-oncology news on his Twitter account.